top of page

Vitamin D in Juvenile Arthritis  

Towards Improved Understanding of the Role of Vitamin D in JIA  

vitamin d logo modified for website background removed rev.png

Innovation

Juvenile Idiopathic Arthritis (JIA; the word 'idiopathic ' means the cause is unknown), is the most common class of childhood rheumatic diseases.  Previous reports suggest that children with JIA are more likely to have suboptimal  vitamin D concentrations compared to healthy controls. It is unknown if low vitamin D concentrations in some children with JIA are a consequence of reduced dietary intake, medication effect, increased utilization related to more disease activity, environmental exposures, or a combination of these factors.  It also is unknown if optimizing vitamin D status in children with JIA could contribute to improved disease control alternatively, if improved disease control is associated with optimization of vitamin D status. The IDEA Lab is undertaking studies to answer these questions. We have shown that Canadian children with JIA tend to have adequate levels of vitamin D and that these adequate levels are associated with taking vitamin D supplements. 

Discovery

In a review of the international literature, the IDEA Lab has shown that children with JIA have inadequate levels of vitamin D.  Read more. We have shown that Canadian children with JIA tend to have adequate levels of vitamin D and that these adequate levels are associated with taking vitamin D supplements and might be related to the season of birth. Read more.

Studies are currently underway to investigate associations between vitamin D and JIA disease activity and associations with genetic variations of the vitamin D receptor. 

Engagement

The IDEA Lab is grateful for the patients and families who have participated in vitamin D related research This work has been supported by The Arthritis Society Canada and The Wiebe Family Fund. We are grateful for collaborations with colleagues in The Colleges of Pharmacy  and Nutrition and Medicine and in Computer Sciences, University of Saskatchewan and pediatric rheumatology colleagues throughout Canada.

Action 

Our results are beginning to generate new knowledge that should provide patients, families, and care providers with clear, evidence-based guidelines for optimizing vitamin D levels in JIA to improve care and outcomes. 

bottom of page